OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High-Throughput CRISPR Screening in Hematological Neoplasms
Raquel Ancos-Pintado, Irene Bragado-García, María Luz Morales, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3612-3612
Open Access | Times Cited: 8
Raquel Ancos-Pintado, Irene Bragado-García, María Luz Morales, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3612-3612
Open Access | Times Cited: 8
Showing 8 citing articles:
CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10
Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia
Shady Adnan Awad, Olli Dufva, Jay Klievink, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101521-101521
Open Access | Times Cited: 7
Shady Adnan Awad, Olli Dufva, Jay Klievink, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101521-101521
Open Access | Times Cited: 7
Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches
Tianning Gu, Meng Zhu, He Huang, et al.
Journal of Zhejiang University SCIENCE B (2022) Vol. 23, Iss. 10, pp. 793-811
Open Access | Times Cited: 23
Tianning Gu, Meng Zhu, He Huang, et al.
Journal of Zhejiang University SCIENCE B (2022) Vol. 23, Iss. 10, pp. 793-811
Open Access | Times Cited: 23
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 5
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 5
Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
Amelia Maria Găman
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9816-9816
Open Access | Times Cited: 3
Amelia Maria Găman
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9816-9816
Open Access | Times Cited: 3
GENETIC DETERMINANTS OF DRUG RESPONSE IN DIFFUSE LARGE B-CELL LYMPHOMA
Issa Ismail Issa
(2024)
Open Access
Issa Ismail Issa
(2024)
Open Access
Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics
Saeideh Khorshid Sokhangouy, Farzaneh Alizadeh, Malihe Lotfi, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 8, pp. 677-702
Closed Access
Saeideh Khorshid Sokhangouy, Farzaneh Alizadeh, Malihe Lotfi, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 8, pp. 677-702
Closed Access
Advances in CRISPR-Cas systems for epigenetics
Mahnoor Ilyas, Qasim Shah, Alvina Gul, et al.
Progress in molecular biology and translational science (2024), pp. 185-209
Closed Access
Mahnoor Ilyas, Qasim Shah, Alvina Gul, et al.
Progress in molecular biology and translational science (2024), pp. 185-209
Closed Access
